Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System
Sponsored by CooperSurgical Inc.
About this trial
Last updated 8 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 16 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Pre-menopausal adult women 30 years of age or older who have completed childbearing
- Heavy or prolonged menstrual bleeding
- Willing and able to complete all follow-up exams as required by protocol
Exclusion Criteria
- Known or suspected endometrial cancer or pre-malignant change of the endometrium
- Untreated cervical dysplasia
- Hereditary malformations of the uterine cavity that would prevent insertion and/or placement of the cryoprobe
- Uterine myomas > or = to 3 cm in diameter
- Past history of invasive treatment for abnormal uterine bleeding or uterine myomas
- History of classical (not low transverse incision) cesarean section
- Active genital or urinary tract infection or acute pelvic inflammatory disease (PID)
- Intrauterine device (IUD) in place
- Other medical conditions could be exclusionary upon evaluation for study treatment